The results showed that BRCA1 carriers with breast cancer who underwent CRRM were less likely to develop CBC (p < 0.0001), and women who developed CBC were twice as likely to die of breast cancer (HR 2.22; 95% CI 1.49–3.32; p < 0.0001). Here, BRCA1 is linked to complete blood cell count.